71 related articles for article (PubMed ID: 26939944)
1. Prostate biopsy, targeted prophylaxis and infectious complications: a critique of methods used.
Roberts MJ; Doi SA
BJU Int; 2016 May; 117(5):719-21. PubMed ID: 26939944
[No Abstract] [Full Text] [Related]
2. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis.
Kisa E
World J Urol; 2018 Jul; 36(7):1175-1176. PubMed ID: 29488094
[No Abstract] [Full Text] [Related]
5. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
Cheung C; Patel HD; Landis P; Carter HB; Han M
Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
[TBL] [Abstract][Full Text] [Related]
6. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
Cussans A; Somani BK; Basarab A; Dudderidge TJ
BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
[TBL] [Abstract][Full Text] [Related]
7. Preprostate Biopsy Rectal Culture and Postbiopsy Sepsis.
Taylor AK; Murphy AB
Urol Clin North Am; 2015 Nov; 42(4):449-58. PubMed ID: 26475942
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness and safety of tazobactam/piperacillin 4.5 g for the prevention of febrile infectious complication after prostate biopsy.
Yasuda M; Nakane K; Yamada Y; Matsumoto M; Sho T; Matsumoto M; Kobayashi K; Shigemura K; Nakano Y; Tanaka K; Hamasuna R; Ishihara S; Arakawa S; Yamamoto S; Matsubara A; Fujisawa M; Deguchi T; Matsumoto T
J Infect Chemother; 2014 Oct; 20(10):631-4. PubMed ID: 25043444
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
Adibi M; Pearle MS; Lotan Y
BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
[TBL] [Abstract][Full Text] [Related]
10. Inoculation of Sphingobacterium multivorum in the prostate by prostate biopsy.
Nielsen TK; Pinholt M; Nørgaard N; Mikines KJ
Scand J Urol; 2014 Feb; 48(1):116-8. PubMed ID: 23834407
[TBL] [Abstract][Full Text] [Related]
11. Stemming the Tide: Infectious Complications After Prostate Biopsy.
Black P
World J Urol; 2015 Jun; 33(6):893, 896-7. PubMed ID: 25985751
[No Abstract] [Full Text] [Related]
12. Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Hernandez-Graulau JM
Urology; 2009 Aug; 74(2):338-9; author reply 339. PubMed ID: 19646618
[No Abstract] [Full Text] [Related]
13. [A case of hepatitis C virus possible transmission following a transrectal ultrasound guided prostate biopsy].
Ferhi K; Haertig A; Mozer P; de la Taille A; Roupret M; Van Glabeke E; Bitker MO
Prog Urol; 2013 Mar; 23(3):222-4. PubMed ID: 23446288
[TBL] [Abstract][Full Text] [Related]
14. Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis.
Cannon GM; Smaldone MC; Paterson DL
Can J Urol; 2007 Aug; 14(4):3653-5. PubMed ID: 17784990
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment.
Unwala DJ
Urology; 2015 Mar; 85(3):516. PubMed ID: 25596155
[No Abstract] [Full Text] [Related]
17. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.
Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS
Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152
[TBL] [Abstract][Full Text] [Related]
18. Does metabolic syndrome increase the risk of infective complications after prostate biopsy? A critical evaluation.
Sahin C; Eryildirim B; Cetinel AC; Faydaci G; Narter F; Goktas C; Sarica K
Int Urol Nephrol; 2015 Mar; 47(3):423-9. PubMed ID: 25588330
[TBL] [Abstract][Full Text] [Related]
19. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Young JL; Liss MA; Szabo RJ
Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
[TBL] [Abstract][Full Text] [Related]
20. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
